Phase I trial of recombinant interferon gamma in cancer patients.

Phase I trial of recombinant interferon gamma in cancer patients.

Item
http://www.wikidata.org/entity/Q40810991
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cellsIron and inflammatory bowel disease.Incorporation of recombinant gamma interferon into liposomes enhances its ability to induce peritoneal macrophage antitoxoplasma activity.Pleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function.Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type I IgG Fc receptors.Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients.The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.Induction of human IgE synthesis by CD4+ T cell clones. Requirement for interleukin 4 and low molecular weight B cell growth factor.Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor traffickingInterferon-γ-induced necrosis: an antitumor biotherapeutic perspective.Interferon for treatment: the dust settles.The role of interferons in the treatment of malignant neoplasms.Adoptive therapy with CAR redirected T cells for hematological malignancies.Gamma interferon treatment in vivo provokes accumulation of activated monocytes in the venous circulation of rats.Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies.
P2860

Phase I trial of recombinant interferon gamma in cancer patients.

Item
http://www.wikidata.org/entity/Q40810991
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Phase I trial of recombinant interferon gamma in cancer patients.
@en
type
label
Phase I trial of recombinant interferon gamma in cancer patients.
@en
prefLabel
Phase I trial of recombinant interferon gamma in cancer patients.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Phase I trial of recombinant interferon gamma in cancer patients.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921